Your browser doesn't support javascript.
loading
CAnceR IN PreGnancy (CARING) - a retrospective study of cancer diagnosed during pregnancy in the United Kingdom.
Baxter, M A; Denholm, M; Kingdon, S J; Kathirgamakarthigeyan, S; Parikh, S; Shakir, R; Johnson, R; Martin, H; Walton, M; Yao, W; Swan, A; Samuelson, C; Ren, X; Cooper, A; Gray, H-L; Clifton, S; Ball, J; Gullick, G; Anderson, M; Dodd, L; Hayhurst, H; Salama, M; Shotton, R; Britton, F; Christodoulou, T; Abdul-Hamid, A; Eichholz, A; Evans, R M; Wallroth, P; Gibson, F; Poole, K; Rowe, M; Harris, J.
Afiliação
  • Baxter MA; Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK. m.z.baxter@dundee.ac.uk.
  • Denholm M; Tayside Cancer Centre, Ninewells Hospital and Medical School, NHS Tayside, Dundee, UK. m.z.baxter@dundee.ac.uk.
  • Kingdon SJ; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Kathirgamakarthigeyan S; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Parikh S; Exeter Oncology Centre, Royal Devon University Hospitals NHS Trust, Exeter, UK.
  • Shakir R; Oncology Department, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Johnson R; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Martin H; Oncology Department, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Walton M; Oncology Department, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Yao W; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Swan A; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Samuelson C; Cancer Research UK Cambridge Institute, Cambridge University, Cambridge, UK.
  • Ren X; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Cooper A; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Gray HL; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK.
  • Clifton S; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK.
  • Ball J; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK.
  • Gullick G; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK.
  • Anderson M; Tayside Cancer Centre, Ninewells Hospital and Medical School, NHS Tayside, Dundee, UK.
  • Dodd L; Bristol Haematology and Oncology Centre, Bristol, UK.
  • Hayhurst H; Bristol Haematology and Oncology Centre, Bristol, UK.
  • Salama M; Oncology Department, Royal United Hospitals NHS Foundation Trust, Bath, UK.
  • Shotton R; Northern Centre for Cancer Care, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, The Newcastle Upon Tyne, UK.
  • Britton F; Northern Centre for Cancer Care, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, The Newcastle Upon Tyne, UK.
  • Christodoulou T; Northern Centre for Cancer Care, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, The Newcastle Upon Tyne, UK.
  • Abdul-Hamid A; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Eichholz A; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Evans RM; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Wallroth P; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Gibson F; Department of Oncology, Royal Surrey County Hospital NHS Trust, Surrey, UK.
  • Poole K; Department of Oncology, Buckinghamshire Healthcare NHS Trust, Buckinghamshire, UK.
  • Rowe M; South West Wales Cancer Centre, Swansea Bay NHS Trust, Swansea, UK.
  • Harris J; Mummy's Star, Glossop, UK.
Br J Cancer ; 130(8): 1261-1268, 2024 May.
Article em En | MEDLINE | ID: mdl-38383704
ABSTRACT

BACKGROUND:

The incidence of cancer diagnosed during pregnancy is increasing. Data relating to investigation and management, as well as maternal and foetal outcomes is lacking in a United Kingdom (UK) population.

METHODS:

In this retrospective study we report data from 119 patients diagnosed with cancer during pregnancy from 14 cancer centres in the UK across a five-year period (2016-2020).

RESULTS:

Median age at diagnosis was 33 years, with breast, skin and haematological the most common primary sites. The majority of cases were new diagnoses (109 patients, 91.6%). Most patients were treated with radical intent (96 patients, 80.7%), however, gastrointestinal cancers were associated with a high rate of palliative intent treatment (63.6%). Intervention was commenced during pregnancy in 68 (57.1%) patients; 44 (37%) had surgery and 31 (26.1%) received chemotherapy. Live births occurred in 98 (81.7%) of the cases, with 54 (55.1%) of these delivered by caesarean section. Maternal mortality during the study period was 20.2%.

CONCLUSIONS:

This is the first pan-tumour report of diagnosis, management and outcomes of cancer diagnosed during pregnancy in the UK. Our findings demonstrate proof of concept that data collection is feasible and highlight the need for further research in this cohort of patients.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cesárea / Neoplasias Limite: Female / Humans / Pregnancy País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cesárea / Neoplasias Limite: Female / Humans / Pregnancy País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido